Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Zhaoke Ophthalmology Ltd. ( (HK:6622) ).
Zhaoke Ophthalmology Ltd. has announced a board meeting scheduled for August 28, 2025, to consider and approve the unaudited interim results for the first half of the year. This meeting is crucial for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the upcoming months.
More about Zhaoke Ophthalmology Ltd.
Zhaoke Ophthalmology Ltd. is a company incorporated in the British Virgin Islands and continued in the Cayman Islands, focusing on the ophthalmology industry. It is listed on the Hong Kong Stock Exchange and specializes in the development of eye care products and services.
Average Trading Volume: 3,533,215
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.18B
See more insights into 6622 stock on TipRanks’ Stock Analysis page.